|
Craig Leon, MBA
Chief Executive Officer and Chairman
Craig Leon is currently the Chief Executive Officer and Chairman of the Board of Directors of Titan Medical Inc., and has been with the Corporation since its inception in 2002. From August 2003 to July 2009, Mr. Leon served as Chief Operating Officer and Chief Financial Officer of Redwood Asset Management Inc. and was registered with GrowthQuest Capital as an associate portfolio manager. From June 2000 to July 2003, Mr. Leon served as a consultant to Generex Biotechnology Corporation (NASDQ: GNBT) (“Generex”) where he was involved in private equity and in business development for the company. While at Generex, Mr. Leon’s responsibilities included the evaluation of strategic investment opportunities, communicating with research analysts and institutions, and participated in company’s investor presentations and road shows. During this time, he was involved in raising the company’s profile on the NASDAQ national market and subsequently being added to the Nasdaq Biotech Index. Mr. Leon was co-founder and Chief Operating Officer at MiFund.com Inc. from 1999 to 2000. MiFund provided global financial institutions with a customized and highly scalable system to facilitate the distribution of proprietary and non-proprietary financial products and services. MiFund, with offices in San Francisco, Paris, Dublin, and Bermuda, raised over $35 million in financing and has partnered with AXA, State Street Bank and DST Systems. Mr. Leon received his undergraduate degree from McGill University and obtained his Masters of Business Administration from York University.
Dr. Reiza Rayman MD, PhD
President, Director
Dr. Rayman’s training in both biophysics and medicine has allowed a broad perspective on new technology and devices as they relate to surgery. As a researcher in fluid dynamics, he concentrated on the role of the fluid dynamics of blood flow as it relates to arteriosclerosis. During subsequent medical training, Dr. Rayman became interested in MIS techniques and devices, and researched the physiologic effects of MIS on infants during prolonged procedures. Additionally, his interest in the device area led to concepts and experimentation using magnetism for bowel retraction during MIS. Dr. Rayman collaborated with Dr. Doug Boyd to implement and develop new techniques related to robotic cardiac surgery. The two performed the world’s first robotic beating heart cardiac bypass surgery in September 1999. Subsequently, Dr. Rayman authored grants to the federal and provincial governments to research several areas of robotic surgery. These grants were successful, and totalled to a program of $30 million, the largest research program in the history of the London Health Sciences Centre. Dr. Rayman has conducted extensive research on substantially all available robotic platforms and is currently an active practitioner who has performed over 400 robotic surgeries. Dr. Rayman held roles including Assistant Professor, Department of Surgery, at the University of Western Ontario. Dr. Rayman holds an M.Sc. (Medical Biophysics) in Fluid Dynamics from The University of Western Ontario, an M.D. from The University of Toronto, and a Ph.D. in Telesurgery from The University of Western Ontario.
Stephen D. Randall, CGA
Chief Financial Officer
Mr. Randall is a Certified General Accountant and has served as an auditor, chief financial officer, corporate controller and accountant for several public and private companies and government organizations. Mr. Randall brings substantial experience in areas such as accounting and finance, tax planning and compliance, information technology management, mergers and acquisitions and operations management.
Dr. John R. Valvo, M.D., F.A.C.S.
Vice President of Medical Affairs
Dr. Valvo is currently the Chief of Urology and Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic program at Rochester General Hospital in early 2004, which currently ranks in the top four percent of robotic surgeries in the United States with over 30 robotic surgeons and over 4,000 robotic surgeries performed to date. Having authored more than 100 scientific articles and helped to create many robotic programs in the northeast, Dr. Valvo's focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery, which has become a template for many upstart robotic surgery programs throughout the country. Additionally, he has experience performing complex urologic surgery for cancers of the genitourinary tract through the surgical platform. He is a fellow of the American College of Surgeons and American Urological Association and is certified by the American Board of Urology. He is also a member of the Monroe County Medical Society, the Minimally Invasive Robotic Association and the Society for Lap Endoscopic Surgeons. Dr. Valvo earned his bachelor of science at Marietta College and his M.D. from SUNY Buffalo.
Joseph Talarico
Senior Vice President, Business Development
Mr. Talarico has been involved in the surgical medical device industry for over seven years, most notably with Intuitive Surgical, Inc. for five years. From 2004 to 2009, Mr. Talarico held various positions with Intuitive Surgical, Inc., including Area Training Director (East Coast), Clinical Sales Manager, Area Sales Manager and Clinical Sales Representative. Mr. Talarico holds a J.D., Law from Syracuse University College of Law and a B.S., Political Science and Sociology from University of Rochester. |
